41![CENTER FOR DRUG EVALUATION AND RESEARCH APPLICATION NUMBER: 021246Orig1s045 and 021087Orig1s062 CENTER FOR DRUG EVALUATION AND RESEARCH APPLICATION NUMBER: 021246Orig1s045 and 021087Orig1s062](https://www.pdfsearch.io/img/ee15bf42d9b50ed1150fe17c7fc4e83a.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2013-04-08 10:07:49
|
---|
42![Advisory Committee for Pharmaceutical Science Advisory Committee for Pharmaceutical Science](https://www.pdfsearch.io/img/b350e5f4cdbbe485dcdcd14abc46fc9c.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
43![MEMORANDUM DEPARTMENT OF HEALTH AND HUMAN SERVICES PUBLIC HEALTH SERVICE FOOD AND DRUG ADMINISTRATION CENTER FOR DRUG EVALUATION AND RESEARCH MEMORANDUM DEPARTMENT OF HEALTH AND HUMAN SERVICES PUBLIC HEALTH SERVICE FOOD AND DRUG ADMINISTRATION CENTER FOR DRUG EVALUATION AND RESEARCH](https://www.pdfsearch.io/img/7530aa21f9e5cc3cc93c7d07b056d98a.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
44![Clinical Pharmacology and Biopharmaceutics Summary _______________________________________________________________________ NDAs: [removed]Serial # SE8-018 Sponsor: GlaxoSmithKline. Clinical Pharmacology and Biopharmaceutics Summary _______________________________________________________________________ NDAs: [removed]Serial # SE8-018 Sponsor: GlaxoSmithKline.](https://www.pdfsearch.io/img/79b18f0983b510cf7fc62143ee718652.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English - Date: 2004-09-14 08:01:32
|
---|
45![Final Draft Review Pharmacometrics Review NDA: DRUG NAME: DOSAGE STRENGTH: Final Draft Review Pharmacometrics Review NDA: DRUG NAME: DOSAGE STRENGTH:](https://www.pdfsearch.io/img/345794ad14091455b7df3703b449c925.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
46![Quantitative and Systems Pharmacology in the Post-genomic Era: New Approaches to Discovering Drugs and Understanding Therapeutic Quantitative and Systems Pharmacology in the Post-genomic Era: New Approaches to Discovering Drugs and Understanding Therapeutic](https://www.pdfsearch.io/img/f49376f353652a7c8638fd4fb73f94eb.jpg) | Add to Reading ListSource URL: www.nigms.nih.govLanguage: English - Date: 2013-09-17 17:32:52
|
---|
47![020838_Candesartan_Clinpharm_BPCA 020838_Candesartan_Clinpharm_BPCA](https://www.pdfsearch.io/img/715ea69931b9da4465e62d8ad43d5806.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
48![Best starting dose meeting the criteria is 0.75 ?g/kg/min. Best starting dose meeting the criteria is 0.75 ?g/kg/min.](https://www.pdfsearch.io/img/ac8f79751b61256a42b465e6758b060b.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
49![Curriculum Vitae: Michael Neely Curriculum Vitae: Michael Neely](https://www.pdfsearch.io/img/e4fc76e308eb181fe0d4b533f8eda1e8.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
50![CHAPTER 1 Pharmacometrics: Impacting Drug Development and Pharmacotherapy INTRODUCTION CHAPTER 1 Pharmacometrics: Impacting Drug Development and Pharmacotherapy INTRODUCTION](https://www.pdfsearch.io/img/e439e7239b734a5df30d7ad6f3684811.jpg) | Add to Reading ListSource URL: media.wiley.comLanguage: English - Date: 2007-10-05 23:12:38
|
---|